Molecular Imaging of Coronary Plaques
Transcript of Molecular Imaging of Coronary Plaques
1
Molecular Imaging of Coronary Plaques
Daniel S. Berman, MDDirector, Cardiac Imaging
Cedars-Sinai Heart Institute
CSMC
Professor of MedicineDavid Geffen School of Medicine at UCLA
CSMC20113
Zahi A. Fayad, PhD, FAHA, FACCP f f R di l d M di i (C di l )Professor of Radiology and Medicine (Cardiology)
Director, Translational and Molecular Imaging InstituteMount Sinai School of Medicine, New York, NY
2
David Newby, MDM k D k MDMark Dweck, MD
University of Edinburgh
Understanding CAD is ChangingUnderstanding CAD is Changing
TCFA with Cap RuptureFibroatheroma: Stable Plaque
Narula & Virmani, 1999Narula & Willerson, JACC (ed)Narula & Willerson, JACC (ed)
3
Anatomical level
Anatomical to Molecular ImagingTissue level
Cellular and molecular Level
Imaging Probes
Sensitivity
PET MRI CT
Payload required
RadioactiveSmall Molecules
ParamagneticSuperparamagnetic
Radiodense
4
Imaging Probes
Sensitivity
PET MRI CT
Payload required
RadioactiveSmall Molecules
ParamagneticSuperparamagnetic
Radiodense
Orders of Magnitude in Drug (Contrast Agent) Dosing:Exploiting the Exploratory IND (eIND) Mechanism
Modality “Typical” Intravenous Human Dose (g)
CT 75 cc of 930 mM solution = 56 g
MRI 15 cc of 500 mM solution = 7 gMRI 15 cc of 500 mM solution 7 g
- - - - - - - - - - 2 Regular Strength Tylenol = 600 mg
Optical (NIR) 5 cc of a 1 mM solution = 5 mg
- - - - - - - - - - FDA definition of micro-dosing = 100 µg
SPECT 20 mCi (10,000 Ci/mmol) = 2 µgeIND‐
PET 20 mCi (10,000 Ci/mmol) = 2 µg Eligible
5
FDG-PET CTa Fused
FDG accumulationRate/sec
10
FDG Uptake in Carotid Artery Disease
Rate/sec
5
P<0.01
symptomaticasymptomaticSymptomsNo symptoms
Weissberg P et al., Circulation 2004
Simvastatin Attenuates Plaque Inflammation
Tahara et al JACC 2006
6
Tawakol et al JACC 2006
Measuring atherosclerosis FDG‐PET/CT
18F‐FDG‐PET/CT imaging5• Identifies cells with increased metabolic activity
• Measures plaque glycolysis (inflammation)
• Used to assess changes in plaque
CT
CT
Used to assess changes in plaque inflammation
• Statins, anti‐inflammatory drugs, TZDs
• Predictor of future risk of atherothrombosis
PET/C
1Rudd et al. Circulation. 2002;105;2708–2711; 2Rudd et al. J Am Coll Cardiol. 2010;55:2527–2735; 3Tahara et al. J Am Coll Cardiol. 2006;48:1825–1831; 4Lee et al. J Nucl Med. 2008;49:1277–1282; 5Fayad et al. The Lancet 2011;378:1547‐1559.
8
Cheng, et al JNM in press 2012
• 27 PCI patients studied with FDG PET/CT1-6 days p PDI: 20 STEMI; 7 stable CAD• Increased uptake in: 12/20 STEMI; 1/7 Stable
Figure 3AXIALCORONAL SAGITTAL
LAD STEMI
FDG Uptake at Stent Site in Acute STEMI
RCA STEMI
LCX STEMI
Cheng, et al JNM in press 2012
9
AXIALCORONAL SAGITTAL
RCA stent for stable CAD
Absence of FDG Uptake at Stent Site in Stable CAD
LAD stent for stable CAD
Cheng, et al JNM in press 2012
Sinusas lecture: ASNC 2009
10
Direct Imaging of Myocardial Ischemia (FDG)
He et al, Narula, Jain. Circulation 2003
18Fluoro-Deoxy Glucose‘The ring of fire’
Aortic Ring InflammationDweck et al. Circulation 2012;125:in press
11
Sodium 18FluorideAortic Stenosis
Dweck et al. Circulation 2012;125:76-86
18Fluoro-Deoxy Glucose‘The ring of fire’
Dweck et al. Circulation 2012;125:76-86
12
Calcification more importantthan Inflammation
Dweck et al. Circulation 2012;125:76-86
Dweck et al JACC 2012
13
F-18 NaF Uptake in Coronary Plaque
Dweck M…Newby D ACC 2012
10 year FRS for Controls and Patients with CAC who did and did
not have 18F-NaF uptake
Dweck et al JACC 2012
14
binding followed by
Annexin V
Detection of theapoptotic cell
TNF orFas Ligand
Tc-99m Annexin V: Probe for Vulnerable Plaque
translocasescramblase
floppase
2D-crystallization
translocase
death domainsmediated signaling
activation of theexecutioner of apoptosis
floppase
?
TNFR orCD95 + +-
Courtesy Chris Reutlingsperger, Maastricht University
Old TIA Recent TIAA B
ANT
L
AnnexinAnnexin--V Imaging For ApoptosisV Imaging For Apoptosis
C D
Transverse
Coronal
AnnexinIHC inEndarterectomy
Keitselaar, Hofstra, Narula; NEJM 2004
15
RGD tracer uptake is increased inatherosclerotic plaque
Oil Red O 18F RGD uptake αvβ3 Autoflour
Tamarappoo, et al 2010
Direct Imaging of Myocardial Ischemia (FDG)
He et al, Narula, Jain. Circulation 2003
16
Molecular Imaging to Detect Vulnerable PlaqueClinial Applications Emerging in 2020
Langer et al. JACC 2008;52:1-12.
Molecular Imaging Across CAD Spectrum
Coronary Calcium/
Stenosis/Perfusion
FunctionGeometry
ConventionalImaging
Coronary Atherosclerosis
MyocardialIschemia/Infarction
HeartFailure
Plaque
MolecularImaging
Disease ActivityPlaque
VulnerabilityRemodeling
Guiding Specifictherapy